(Q72358571)
Statements
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial (English)
E Bayever
M R Bishop
J G Sharp
H K Tewary
M A Arneson
S J Pirruccello
R W Ruddon
A Kessinger
1 January 1993